Correlation Between Grace Therapeutics, and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Grace Therapeutics, and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grace Therapeutics, and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grace Therapeutics, and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Grace Therapeutics, and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grace Therapeutics, with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grace Therapeutics, and Cyclacel Pharmaceuticals.
Diversification Opportunities for Grace Therapeutics, and Cyclacel Pharmaceuticals
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Grace and Cyclacel is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Grace Therapeutics, and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Grace Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grace Therapeutics, are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Grace Therapeutics, i.e., Grace Therapeutics, and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Grace Therapeutics, and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Grace Therapeutics, is expected to generate 0.71 times more return on investment than Cyclacel Pharmaceuticals. However, Grace Therapeutics, is 1.41 times less risky than Cyclacel Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 321.00 in Grace Therapeutics, on August 27, 2024 and sell it today you would earn a total of 23.00 from holding Grace Therapeutics, or generate 7.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Grace Therapeutics, vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Grace Therapeutics, |
| Cyclacel Pharmaceuticals |
Grace Therapeutics, and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Grace Therapeutics, and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Grace Therapeutics, and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grace Therapeutics, position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Grace Therapeutics, vs. Vivani Medical | Grace Therapeutics, vs. Verve Therapeutics | Grace Therapeutics, vs. Bright Minds Biosciences | Grace Therapeutics, vs. Alpha Tau Medical |
| Cyclacel Pharmaceuticals vs. Absci Corp | Cyclacel Pharmaceuticals vs. Larimar Therapeutics | Cyclacel Pharmaceuticals vs. InMed Pharmaceuticals | Cyclacel Pharmaceuticals vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |